MedPath

Effects of topical magnesium sulfate on progression of labor

Phase 2
Recruiting
Conditions
Active phase and progression of Labor in nulliparous women.
Registration Number
IRCT20201024049128N3
Lead Sponsor
Alborz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
148
Inclusion Criteria

Pregnant women with gestational age of 37 to 42 weeks
First labor
Single fetus weighting between 3.5 - 4 kg
Low risk, non-induced labor
BMI of the mother being between 19.8 and 30 kg/m2

Exclusion Criteria

Any sign indicating fetal heart rate abnormalities, placenta abruption, cord prolapse or anything that pregnancy is high risk
Cephalopelvic disproportion
Mothers' chronic underlying disease like anemia, hemophilia, cardiopulmonary or neuromuscular disease
Any sign of allergy or toxicity caused by magnesium sulfate

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath